Law360 (May 30, 2007, 12:00 AM EDT) -- Bristol-Myers Squibb Co. pled guilty and agreed to pay a $1 million fine Wednesday for allegedly lying to the federal government about its Plavix patent deal with Apotex Corp.
The two-count criminal charge was filed in the U.S. District Court for the District of Columbia by Assistant Attorney General Thomas O. Barnett.
Bristol-Myers Squibb agreed not to launch its own generic version of Plavix that would compete against Apotex for generic sales despite the Federal Trade Commission's refusal to approve the companies' deal if such an agreement was made, according to the complaint.
The complaint further alleged that Bristol-Myers tried to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!